Seek Returns

AVTR vs. BMY: Avantor vs. Bristol-Myers Squibb Stock Comparison

How do Avantor (AVTR) and Bristol-Myers Squibb (BMY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Avantor (AVTR) and Bristol-Myers Squibb (BMY) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but AVTR is classified in Life Sciences Tools & Services while BMY is classified in Pharmaceuticals.

Company profile comparison for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
Profile ItemAVTRBMY
NameAvantor, Inc.Bristol-Myers Squibb Company
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesPharmaceuticals
GICS Sub-IndustryLife Sciences Tools & ServicesPharmaceuticals
Market Capitalization10.48 billion USD127.02 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateMay 17, 2019June 1, 1972
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

AVTR
BMY
GSPC
Loading price history…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Avantor (AVTR) and Bristol-Myers Squibb (BMY). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Avantor (AVTR) and Bristol-Myers Squibb (BMY). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
Total Return (1Y)36.41%38.62%
Total Return (3Y, Annualized)-5.02%12.29%
Total Return (5Y, Annualized)-16.62%5.09%

Risk Profile

Drawdown History

AVTR
BMY
GSPC
Loading price history…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Avantor (AVTR) and Bristol-Myers Squibb (BMY). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
Volatility (1Y, Annualized)43.39%28.01%
Beta (5Y)0.940.19
Max Drawdown (5Y)-82.42%-47.67%
Avg. Volume (3M)8.56M10.85M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
AVTR and BMY are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
Sharpe Ratio (1Y)0.741.23
Sortino Ratio (1Y)1.171.95

Profitability

ROE (TTM)

Bristol-Myers Squibb (BMY) at 44.01% sits in the top ROE quartile, while Avantor (AVTR) at 5.91% is closer to the peer norm — stronger capital efficiency for BMY.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.91%

Max
109.18%
Q3
6.23%
AVTR
5.91%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

44.01%

Max
109.18%
BMY
44.01%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Bristol-Myers Squibb (BMY) at 18.47% keeps the most of each sales dollar — above its industry’s net margin range — and Avantor (AVTR) at 5.08% also retains a top-quartile share.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.08%

Max
18.05%
AVTR
5.08%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.47%

BMY
18.47%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Bristol-Myers Squibb (BMY) at 33.79% operates in the top operating margin quartile, ahead of Avantor (AVTR) at 8.19%, which runs around its industry’s norm.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.19%

Max
83.12%
Q3
14.77%
AVTR
8.19%
Median
0.00%
Q1
-78.82%
Min
-207.40%

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.79%

Max
83.12%
BMY
33.79%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
ROE (TTM)5.91%44.01%
ROA (TTM)2.83%10.90%
Net Margin (TTM)5.08%18.47%
Operating Margin (TTM)8.19%33.79%
Gross Margin (TTM)31.59%70.50%

Growth

Revenue Growth

Bristol-Myers Squibb (BMY) at -0.22% is around its peer norm for revenue growth, while Avantor (AVTR) at -3.41% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Avantor (AVTR) reports EPS growth of -175.00%, ranked against its industry; Bristol-Myers Squibb (BMY) has no EPS growth figure this period.

Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
Revenue Growth (YoY)-3.41%-0.22%
Revenue Growth (3Y CAGR)-4.46%1.45%
EPS Growth (YoY)-175.00%--
EPS Growth (3Y CAGR)--5.46%

Financial Strength

Current Ratio (MRQ)

Both Avantor (AVTR) at 1.89 and Bristol-Myers Squibb (BMY) at 1.59 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.89

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
AVTR
1.89
Min
0.10

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.59

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
BMY
1.59
Min
0.10
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Avantor (AVTR) at 0.63 is near its industry mid-range for debt-to-equity ratio, while Bristol-Myers Squibb (BMY) at 1.91 sits above its benchmark range, pointing to a heavier debt load relative to equity.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.63

Max
1.42
Q3
0.65
AVTR
0.63
Median
0.15
Q1
0.02
Min
0.00

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.91

BMY
1.91
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
Current Ratio (MRQ)1.891.59
Debt / Equity (MRQ)0.631.91
Net Debt / EBITDA3.401.77

Dividends

Dividend Yield (TTM)

Avantor (AVTR) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Bristol-Myers Squibb (BMY) reports a yield of 3.99%, ranking against industry peers normally.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

AVTR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.99%

BMY
3.99%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Avantor (AVTR) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Bristol-Myers Squibb (BMY) reports a payout of 55.88%, ranking against industry peers normally.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

AVTR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

55.88%

BMY
55.88%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
Dividend Yield (TTM)0.00%3.99%
Dividend Payout Ratio (TTM)0.00%55.88%

Valuation

P/E Ratio (TTM)

Both Avantor (AVTR) at 30.94 and Bristol-Myers Squibb (BMY) at 13.78 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.94

Max
85.34
Q3
43.46
AVTR
30.94
Median
26.69
Q1
13.30
Min
0.07

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.78

Max
85.34
Q3
43.46
Median
26.69
BMY
13.78
Q1
13.30
Min
0.07
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

Both Avantor (AVTR) at 1.58 and Bristol-Myers Squibb (BMY) at 2.54 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.58

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
AVTR
1.58
Min
0.01

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.54

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
BMY
2.54
Min
0.01
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Avantor (AVTR) at 1.80 and Bristol-Myers Squibb (BMY) at 5.43 are valued close to their industries’ norm against book — neither stands out from peers.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.80

Max
13.53
Q3
6.54
Median
3.25
AVTR
1.80
Q1
1.69
Min
-5.59

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.43

Max
13.53
Q3
6.54
BMY
5.43
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Avantor (AVTR) vs. Bristol-Myers Squibb (BMY): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Avantor (AVTR) and Bristol-Myers Squibb (BMY)
MetricAVTRBMY
P/E Ratio (TTM)30.9413.78
P/S Ratio (TTM)1.582.54
P/B Ratio (MRQ)1.805.43
Free Cash Flow Yield (TTM)4.21%5.01%